[
    [
        {
            "time": "",
            "original_text": "智飞生物：目前公司管线内有26个在研项目，主要涉及预防肺结核、肺炎、流脑、流感、狂犬病等人用疫苗项目",
            "features": {
                "keywords": [
                    "智飞生物",
                    "在研项目",
                    "疫苗",
                    "肺结核",
                    "肺炎",
                    "流脑",
                    "流感",
                    "狂犬病"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "智飞生物：目前公司管线内有26个在研项目，主要涉及预防肺结核、肺炎、流脑、流感、狂犬病等人用疫苗项目",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药板块2021Q3分析暨11月月报：高基数下增速放缓 板块基本面依旧强劲 把握配置窗口期",
            "features": {
                "keywords": [
                    "医药板块",
                    "2021Q3",
                    "高基数",
                    "增速放缓",
                    "基本面强劲",
                    "配置窗口期"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药板块2021Q3分析暨11月月报：高基数下增速放缓 板块基本面依旧强劲 把握配置窗口期",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]